切除的非小细胞肺癌患者的身体成分与手术前的萨科佩尼亚:一个倾向匹配分析
Zhu-Zhu Wang1,2, Jin-Yu He2, Rui-Feng Tang2
1The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
Journal of cachexia, sarcopenia and muscle
|February 13, 2026
概括
早期非小细胞肺癌 (NSCLC) 中的肉症涉及到广泛的身体组成枯竭,而不仅仅是肌肉损失. 生物电阻分析 (BIA) 揭示了不同的性别特异性模式,有助于评估这些复杂的变化.
科学领域:
- 在瘤学瘤学.
- 老年学是指老年学的学科.
- 营养科学 营养科学
背景情况:
- 萨科佩尼亚是早期非小细胞肺癌 (NSCLC) 的已知预后因素.
- 在患有肉类的NSCLC患者中,综合体构成 (BC) 的变化尚不清楚.
- 这项研究调查了手术前肉类的早期NSCLC患者的BC变化,重点关注性别差异.
研究的目的:
- 通过使用生物电阻分析 (BIA) 在手术前肉症的早期NSCLC患者中划分身体组成 (BC) 的变化.
- 为了确定与肉类相关的BC变化中的性别特异性差异.
- 在这个人群中确定与肉症相关的独立BC因子.
主要方法:
- 一项病例对照研究,涉及460名患有I-II期NSCLC的患者.
- 根据亚洲麻症工作组2019年标准进行了手术前诊断的麻症.
- 多频BIA在手术前进行,随后进行倾向性得分匹配 (PSM) 和多变量后勤回归.
主要成果:
- 匹配分析显示,与非sarcopenic患者相比,sarcopenic患者的身体脂肪质量,身体细胞质量,骨矿物质含量和基础代谢率显著降低.
- 截然不同的性别特异现象:女性表现出协调的肌肉,脂肪和矿物质耗尽,而男性则有孤立的肌肉损失.
- 尾骨肌肉质量,体脂质量和基本代谢率是与肉症相关的独立因素;几个BC参数的性别修改关联.
结论:
- 在早期NSCLC中,手术前的肉类是多隔间枯竭综合征,具有细胞和代谢障碍.
- 在NSCLC患者中存在明显的性别特异性的肉类现型.
- BIA是多维BC评估的宝贵工具,支持制定适合性别的预康复策略.
相关概念视频
Composite Bodies
1.4K
A composite body is a body made up of multiple parts, connected to form a larger, unified object. Each part has its own weight and center of gravity, which must be considered to determine the center of gravity of the composite body. In cases where the density or specific weight is constant, the center of gravity coincides with the centroid.
Composite bodies have widespread applications in mechanical engineering, from automobiles to aircraft to rockets. For example, an automobile wheel comprises...
Composite bodies have widespread applications in mechanical engineering, from automobiles to aircraft to rockets. For example, an automobile wheel comprises...
1.4K
Composition of Body Fluids
2.7K
Water functions as a solvent accommodating various solutes, which can be categorized under electrolytes and non-electrolytes. Non-electrolytes are usually held together by covalent bonds, restricting them from dissociating in solution, thereby leading to a lack of electrically charged components upon dissolving in water. They are predominantly organic molecules, such as glucose, creatinine, and urea. Electrolytes, on the other hand, are compounds that can break down into ions in water.
2.7K
Sign Test for Matched Pairs
428
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
To conduct the sign test, we first calculate the differences in...
428
Lung Capacity
56.4K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.4K
Classifying Matter by Composition
91.7K
Matter: Pure Substances and Mixtures
According to its composition, the matter can be classified into two broad categories — pure substances and mixtures.
A pure substance is a form of matter that has a constant composition throughout with uniform properties. For example, any sample of sucrose has the same composition and same physical properties, such as melting point, color, and sweetness, regardless of the source from which it is isolated.
A mixture is composed of two or...
According to its composition, the matter can be classified into two broad categories — pure substances and mixtures.
A pure substance is a form of matter that has a constant composition throughout with uniform properties. For example, any sample of sucrose has the same composition and same physical properties, such as melting point, color, and sweetness, regardless of the source from which it is isolated.
A mixture is composed of two or...
91.7K
Cancer Survival Analysis
774
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
774


